PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,371,000 | -37.2% | 539,263 | -16.5% | 0.24% | -34.9% |
| Q2 2021 | $8,553,000 | -65.4% | 646,001 | -54.3% | 0.37% | -57.4% |
| Q1 2021 | $24,708,000 | -35.0% | 1,413,508 | -4.9% | 0.87% | -48.9% |
| Q4 2020 | $38,024,000 | +32.3% | 1,487,038 | -32.1% | 1.70% | +2.2% |
| Q3 2020 | $28,730,000 | -52.9% | 2,191,453 | -1.7% | 1.66% | -62.0% |
| Q2 2020 | $60,935,000 | +73.5% | 2,229,587 | 0.0% | 4.37% | +37.3% |
| Q1 2020 | $35,116,000 | – | 2,229,587 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |